Le Lézard
Classified in: Health, Business
Subjects: SVY, ECO

Herbals & Naturals Seeing Increased Use Across Largest Consumer Health Markets Globally According to New Nicholas Hall Group Report


LONDON, September 19, 2018 /PRNewswire/ --

Consumers in some of the largest healthcare markets globally are increasingly turning to herbal & natural medicines and supplements, fuelling a huge boom in sales of Herbals & Naturals, according to a new report from The Nicholas Hall Group.

The new Herbals & Naturals report found that 9 markets (Australia, Brazil, Canada, China, Germany, India, Italy, Japan, USA) together added US$1,564mn in net sales in 2017, with China and USA the largest contributors. The combined Herbals & Naturals category in these markets totalled $33bn in 2017, growing by 5.0%, well ahead of growth of allopathic medicines at just 3.0%.

Some of the factors driving this growth include health & wellness climbing up the list of consumer priorities and herbal & natural options gaining prominence thanks to being suitable for children and perceived as safer than allopathic options. With medicated ingredients increasingly scrutinised and restricted, consumer concerns have risen about the safety of conventional medicines. Herbals & naturals have an increasing reputation for efficacy, with scientific studies / clinical backing enhancing the standing of many H&N brands.

Probiotics form the single fastest-growing category among Herbals & Naturals (averaging +11% a year since 2013), driven by rising awareness of benefits, consumer focus on prevention, expansion into new niches and increasing segmentation. Positioning of many probiotics has evolved beyond well-established gastrointestinal health and immunity benefits into multiple areas, including women's health, mother & baby, metabolic, stress, healthy ageing, etc. Options for children are proving particularly popular.

Other growth areas include herbal & natural cough remedies (averaging +8% growth a year) and topical analgesics (+7% a year). Herbal & natural cough is enjoying a surge in demand, helped by safety concerns over allopathic options and restrictions placed on certain ingredients (DXM, codeine); plenty of launch activity, with ivy extract, thyme and honey the key growth segments. Among pain gels & rubs, the efficacy of herbal & natural formulations is highlighted, many brands relying on trusted heritage, with celebrity endorsement critical in markets like Japan and USA. Menthol and camphor are common and popular ingredients, alongside methyl salicylate, comfrey, capsaicin and arnica. China is dominated by TCMs, India by ayurvedic remedies, while homeopathics are significant in Europe and USA.

The full report, Herbals & Naturals: Opportunities in a Vast & Dynamic Area of Consumer Health, is available now and more details can be found here: https://nicholashall.com/report/herbals-naturals

For more details contact [email protected], +44(0)1702-220-200


These press releases may also interest you

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...

at 17:05
Sirona Biochem Corp. ("Sirona") announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024. The total number of shares represented by shareholders present in...



News published on and distributed by: